Full video transcriptClick to expand
Auto-generated transcript of @dt.roth's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00And my SHBG was a 4.9 or 4.4, very low.
- 0:05And I was like, well, at least my Tissant Jones
- 0:07getting into it was, right?
- 0:08But then I lose the prostate health
- 0:11and the heart health factors.
- 0:14But I feel on this is my opinion.
- 0:17If it is low, you can do other things
- 0:21to mitigate side effects or any long-term things
- 0:25for your heart and prostate, right?
- 0:27That I think would be the right way of doing it.
SHBG and TRT: What the hormone actually does to your testosterone
Quick answer
The creator reports an SHBG level of approximately 4.4 to 4.9 nmol/L while on testosterone replacement therapy, a reading well below the standard male reference range of 10 to 57 nmol/L. At this level, the ratio of free to bound androgen is significantly altered, raising questions about erythrocytosis risk, cardiovascular signaling, and androgen receptor dynamics that extend beyond what lifestyle modifications alone are likely to address. Any management decisions around severely suppressed SHBG in the context of exogenous testosterone use should involve full panel review and physician oversight, not self-directed mitigation strategies.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For SHBG and TRT: What the hormone actually does to your testosterone, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
SHBG and TRT: What the hormone actually does to your testosterone should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "SHBG and TRT: What the hormone actually does to your testosterone" from DT Roth. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator reports an SHBG level of approximately 4.
The reason this review is not generic is the source wording and the canonical claim label "trt shbg shbg fyp lifexmd test testosteronetherapy testosteroner." In this clip, the useful excerpt is: "And my SHBG was a 4." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator reports an SHBG level of approximately 4.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator reports an SHBG level of approximately 4.4 to 4.9 nmol/L while on testosterone replacement therapy, a reading well below the standard male reference range of 10 to 57 nmol/L. At this level, the ratio of free to bound androgen is significantly altered, raising questions about erythrocytosis risk, cardiovascular signaling, and androgen receptor dynamics that extend beyond what lifestyle modifications alone are likely to address. Any management decisions around severely suppressed SHBG in the context of exogenous testosterone use should involve full panel review and physician oversight, not self-directed mitigation strategies.
- SHBG between 4 and 5 nmol/L is severely low by clinical standards; the typical male reference range runs from 10 to 57 nmol/L according to most endocrinology lab references.
- Exogenous testosterone suppresses SHBG production, meaning TRT itself can create or worsen low SHBG in a feedback loop that is difficult to reverse without adjusting the protocol.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- SHBG between 4 and 5 nmol/L is severely low by clinical standards; the typical male reference range runs from 10 to 57 nmol/L according to most endocrinology lab references.
- Exogenous testosterone suppresses SHBG production, meaning TRT itself can create or worsen low SHBG in a feedback loop that is difficult to reverse without adjusting the protocol.
- Ding et al. (2015, JAMA Internal Medicine) found low SHBG independently associated with metabolic syndrome and type 2 diabetes risk, both of which amplify cardiovascular burden.
- Hammond (2016, Journal of Endocrinology) documented that SHBG has direct receptor-mediated activity in tissues, meaning it is not simply a passive carrier protein, and its suppression has effects beyond free testosterone math.
- Lifestyle changes such as alcohol reduction, weight loss, and lower refined carbohydrate intake can raise SHBG modestly, but evidence for meaningful correction in severely suppressed cases while on TRT is limited.
- Hematocrit and red blood cell changes are among the most monitored safety markers in TRT management, and very low SHBG with high free testosterone levels can contribute to erythrocytosis risk that was not mentioned in the video.
- Anyone managing an SHBG reading this far outside normal range on a hormone protocol should have that interpreted by a licensed provider in the context of a full panel, not addressed with self-directed mitigation alone.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @dt.roth actually say?
The creator disclosed that their SHBG came back somewhere between 4.4 and 4.9, which is genuinely quite low. They acknowledged that while low SHBG means more free testosterone is available, it comes with trade-offs: reduced prostate and heart health protection. Their conclusion was that "if it is low, you can do other things to mitigate side effects" rather than treating the number as a dealbreaker. That framing is worth examining carefully.
To be clear, this isn't a dramatic or reckless claim. It's a personal reflection with a qualifying disclaimer: "this is my opinion." That kind of epistemic humility is rare in hormone content on TikTok. But opinion or not, the underlying assumptions deserve scrutiny because low SHBG in the context of exogenous testosterone carries real clinical implications that go beyond lifestyle tweaks.
Does the science back this up?
Partly. The basic physiology is correct: SHBG binds sex hormones, and low SHBG correlates with higher free testosterone bioavailability. The cardiovascular and prostate concern is also real, though it's more nuanced than the creator suggests.
SHBG has been identified as an independent predictor of cardiovascular risk in several large cohort studies. Ding et al. (2015, JAMA Internal Medicine) found that low SHBG was associated with increased risk of type 2 diabetes and metabolic syndrome, both of which are cardiovascular risk amplifiers. Separately, research from Holmberg et al. (2012, NEJM) and later analyses from the SPCG-4 trial suggested SHBG interacts with androgen signaling in prostate tissue in ways that aren't fully understood.
The idea that lifestyle interventions can "mitigate" these risks isn't baseless. Diet, exercise, and weight management do influence SHBG levels and metabolic health. But the claim that these measures can fully offset the risks of sustained, very low SHBG while on TRT lacks strong clinical evidence. A level of 4.4 to 4.9 is below most laboratory reference ranges by a significant margin, and that context is missing from the video.
What did they get wrong (or right)?
They got the basic mechanism right. Low SHBG does increase free testosterone, and that's the reason some TRT users end up with this pattern: exogenous testosterone suppresses SHBG production, which then loops back to change the free-to-total testosterone ratio.
What's missing is precision. SHBG in the range of 4 to 5 nmol/L isn't just "low." It's severely low. Normal adult male ranges typically run from 10 to 57 nmol/L. At these levels, erythrocytosis risk, hematocrit elevation, and potential blood viscosity changes become more clinically relevant, not just prostate and cardiac signaling. The creator doesn't mention hematocrit, which is arguably the most monitored safety marker in TRT management.
The suggestion to "do other things to mitigate" is vague enough to be either reasonable or misleading depending on what those things are. If they mean regular bloodwork, cardiovascular exercise, and physician monitoring, that's defensible. If they mean supplements or anecdotal protocols circulating in TRT communities, the evidence base is thin.
What should you actually know?
SHBG is not just a testosterone transport protein. It has its own receptor activity and influences signaling in ways researchers are still mapping. A review by Hammond (2016, Journal of Endocrinology) summarizes the emerging evidence that SHBG acts directly on tissues, not just as a passive carrier. Treating a very low SHBG reading as something to simply route around with lifestyle changes underestimates what we don't yet know.
If you're on TRT and your SHBG comes back this low, the appropriate response is a conversation with a licensed provider who can interpret the full panel, including free testosterone, total testosterone, estradiol, hematocrit, PSA, and lipids together. No single number in isolation tells the whole story.
- SHBG below 10 nmol/L is considered clinically low by most endocrinology guidelines.
- Low SHBG is associated with insulin resistance and metabolic syndrome independent of testosterone levels.
- Lifestyle factors like alcohol reduction, weight loss, and dietary changes can modestly raise SHBG, but the effect size in severely low cases is limited.
- Exogenous testosterone itself tends to suppress SHBG, which can create a feedback loop that's difficult to reverse without adjusting the TRT protocol.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
DT Roth · TikTok creator
17.4K views on this video
SHBG???? - #shbg #fyp #lifexmd #test #testosteronetherapy #testosteronereplacement #hgh #gear
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about shbg between 4?
SHBG between 4 and 5 nmol/L is severely low by clinical standards; the typical male reference range runs from 10 to 57 nmol/L according to most endocrinology lab references.
What does the video say about exogenous testosterone suppresses shbg production, meaning trt itself can create?
Exogenous testosterone suppresses SHBG production, meaning TRT itself can create or worsen low SHBG in a feedback loop that is difficult to reverse without adjusting the protocol.
What does the video say about ding et al. (2015, jama internal medicine) found low shbg?
Ding et al. (2015, JAMA Internal Medicine) found low SHBG independently associated with metabolic syndrome and type 2 diabetes risk, both of which amplify cardiovascular burden.
What does the video say about hammond (2016, journal of endocrinology) documented?
Hammond (2016, Journal of Endocrinology) documented that SHBG has direct receptor-mediated activity in tissues, meaning it is not simply a passive carrier protein, and its suppression has effects beyond free testosterone math.
What does the video say about lifestyle changes such as alcohol reduction, weight loss,?
Lifestyle changes such as alcohol reduction, weight loss, and lower refined carbohydrate intake can raise SHBG modestly, but evidence for meaningful correction in severely suppressed cases while on TRT is limited.
What does the video say about hematocrit?
Hematocrit and red blood cell changes are among the most monitored safety markers in TRT management, and very low SHBG with high free testosterone levels can contribute to erythrocytosis risk that was not mentioned in the video.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by DT Roth, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.